Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza A Virus, H1N1 Subtype”

14 trials

Showing 14 of 14 results

Post-approval studies (Phase 4)Study completedNCT01063608
What this trial is testing

Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.

Who this might be right for
Influenza A Virus, H1N1 Subtype
Institut National de la Santé Et de la Recherche Médicale, France 147
Testing effectiveness (Phase 2)Study completedNCT00978120
What this trial is testing

Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma

Who this might be right for
H1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 390
Large-scale testing (Phase 3)Study completedNCT01053143
What this trial is testing

Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India

Who this might be right for
InfluenzaPandemic InfluenzaInfluenza A Virus, H1N1 Subtype
Sanofi Pasteur, a Sanofi Company 100
Large-scale testing (Phase 3)Study completedNCT00996138
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

Who this might be right for
Influenza
Novartis Vaccines 200
Not applicableStudy completedNCT01098786
What this trial is testing

Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 556
Early research (Phase 1)Study completedNCT00989404
What this trial is testing

Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days

Who this might be right for
Influenza A Virus, H1N1 Subtype
GlaxoSmithKline 18
Large-scale testing (Phase 3)Study completedNCT01231620
What this trial is testing

Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

Who this might be right for
Influenza, Human
GlaxoSmithKline 626
Large-scale testing (Phase 3)Study completedNCT01000207
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 123
Large-scale testing (Phase 3)Study completedNCT01016548
What this trial is testing

Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

Who this might be right for
LymphomaMultiple MyelomaInfluenza A Virus, H1N1 Subtype
University Health Network, Toronto 42
Testing effectiveness (Phase 2)Study completedNCT01014988
What this trial is testing

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

Who this might be right for
Influenza, Human
GlaxoSmithKline 202
Not applicableUnknownNCT01053533
What this trial is testing

A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza

Who this might be right for
Influenza A Virus, H1N1 Subtype
Beijing Ditan Hospital 1,100
Testing effectiveness (Phase 2)Study completedNCT00992836
What this trial is testing

Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

Who this might be right for
HIV InfectionsH1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 155
Post-approval studies (Phase 4)Study completedNCT01069367
What this trial is testing

Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 100
Early research (Phase 1)Study completedNCT00973895
What this trial is testing

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Who this might be right for
Influenza A Virus, H1N1 SubtypeNovel Swine-Origin
National Institute of Allergy and Infectious Diseases (NIAID) 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation